Search

everythinglearnresearchcommunity

for

Search:↓

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

The EpiLight Hair Removal System removed about 60% of hair with some side effects, and more research is needed to confirm long-term effectiveness.

Fractional bipolar RF energy safely and effectively treats acne scars.

Applying calreticulin can speed up wound healing in diabetics.

The new hyaluronic acid gel is as safe and effective for lip enhancement as the existing product.

Combination therapies can improve hair loss treatment results and boost self-confidence in men.

Follow these guidelines to safely and effectively use energy-based devices in aesthetic treatments.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Stem cells, PRP, and exosomes show promise in treating skin conditions but face regulatory and safety challenges.

The September 2023 issue highlights the importance of safety in cosmetic procedures and updates on treatments for acne, rosacea, and hair restoration.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

The May 2021 issue of the Journal of Cosmetic Dermatology suggests injectables are becoming more reliable and may reduce the need for cosmetic surgery.

The July 2019 journal had articles on rosacea treatment and herbal hair loss remedies.

The September 2018 Journal of Cosmetic Dermatology covered various dermatology topics and emphasized its dedication to diverse global contributions.

The combined technology safely and effectively removes hair at home on dark skin.

Activating telomerase can boost hair follicle stem cell growth and hair production.

The Naked (N) trait in mice is linked to lower glycine and tyrosine in hair proteins.

Hair loss and growth can be accurately measured using computer-assisted counting.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.